Please provide your email address to receive an email when new articles are posted on . The FDA announced approval of the first generic of Symbicort — budesonide and formoterol fumarate dihydrate — ...
The U.S. Food and Drug Administration said yesterday that it has given approval for the first generic of the Symbicort inhaler to treat asthma and COPD. Symbicort is a combination of budesonide and ...
Viatris and Kindeva Drug Delivery announced that Mylan, a Viatris subsidiary, has received the Food and Drug Administration's green light for Breyna, which is the first generic of AstraZeneca’s ...
There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...
This year’s most-read articles on asthma spotlighted the first generic metered dose inhaler approved by the FDA, the effectiveness of exercise interventions, and more. The relationship between asthma ...
The situation is an ironic one. While climate change is worsening respiratory illnesses — by increasing extreme heat, spreading smoke from wildfires, and lowering air quality — one of the most common ...
PORTLAND, Ore., Nov. 26, 2025 /PRNewswire/ -- Summary: Metered Dose Inhalers (MDIs) are widely used in the treatment and management of respiratory conditions such as asthma and chronic obstructive ...
LONDON--(BUSINESS WIRE)--The global digital dose inhalers market size will grow by USD 989.44 million during 2019-2023. This market report provides a detailed analysis of the market by product ...
(RTTNews) - The U.S. Food and Drug Administration approved Mylan Pharmaceuticals, Inc.'s generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol. It is the first FDA- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback